This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and preclinical development services worldwide.View CRL key stats
Charles River Laboratories International In - CRL - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Charles River Laboratories International In as a
Buy with a ratings score of A.
Report Snippet: We rate Charles River Laboratories International In (CRL) a Buy.
This is based on the convergence of positive investment measures, which should help this stock outperform the majority
of stocks that we rate. The company's strengths can be seen in multiple areas, such as its solid stock price performance,
growth in earnings per share, revenue growth, notable return on equity and expanding profit margins. Although the company
may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.